Press release
Branded Generics Market worth $1,126.43 billion by 2030, growing at a CAGR of 14.66% - Exclusive Report by 360iResearch
Branded Generics Market | 360iResearch
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/branded-generics?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Branded generics, comprising generic drugs marketed under a pharmaceutical brand name, differ from conventional generics by often commanding higher prices due to brand trust. These drugs, maintaining identical active ingredients and formulations as original branded drugs, offer cost-effective alternatives with assured quality and efficacy, benefiting patients, healthcare providers, and pharmaceutical companies as they navigate markets losing patent protections. Widely applicable in therapeutic fields such as oncology, cardiovascular diseases, and chronic conditions, branded generics are extensively used in hospitals, clinics, and pharmacies. Increasing chronic disease prevalence, healthcare cost management pressures, favorable regulatory policies, and the expiration of patents drive their market growth. Opportunities lie in emerging markets, strategic partnerships with local companies, innovative drug delivery systems, patient education programs, and leveraging digital platforms for promotion. However, the market faces challenges such as price pressure, intense competition from unbranded generics and biosimilars, regulatory hurdles, and counterfeit drugs. Innovation and research areas include advanced formulations, exploration of branded generic versions of biologics and biosimilars, digital health integration, sustainable manufacturing processes, and the use of AI and big data analytics. The branded generics market is dynamic and competitive, influenced by global healthcare trends, presenting growth opportunities despite demands for continual innovation, strategic positioning, and regulatory navigation. The future of the market appears optimistic, contingent on effective management of challenges and capitalization on emerging opportunities.
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/branded-generics?utm_source=openpr&utm_medium=referral&utm_campaign=inquire
Market Segmentation & Coverage:
This research report categorizes the Branded Generics Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Product, market is studied across Trade Named Generics and Value-Added.
Based on Drug Type, market is studied across Alkylating Agents, Anti-depressants, Anti-epileptics, Anti-hypertensive, Anti-psychotics, Antimetabolites, Hormones, and Lipid Lowering Drugs.
Based on Route of Administration, market is studied across Oral, Parenteral, and Topical.
Based on Indication, market is studied across Acute & Chronic Pain, Cardiovascular Diseases, Dermatological Diseases, Gastrointestinal Diseases, Neurological Diseases, and Oncology.
Based on Distribution Channel, market is studied across Offline and Online. The Offline is further studied across Hospital Pharmacy and Retail Pharmacy.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Key Company Profiles:
The report delves into recent significant developments in the Branded Generics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Ajanta Pharma Ltd., Alkem Laboratories Ltd., Amneal Pharmaceuticals LLC, Apotex Inc., Aspen Pharmacare Holdings Limited, AstraZeneca PLC, Aurobindo Pharma Limited, Bausch Health Companies Inc., Bristol-Myers Squibb Company, Cipla Limited, Dr. Reddy's Laboratories Ltd., Endo International PLC, Eris Lifesciences Limited, Eva Pharma, Fresenius Kabi AG, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Hetero Drugs Limited, Lupin Limited, Micro Labs Limited, Nichi-Iko Pharmaceutical Co., Ltd., Pfizer Inc., Sandoz International GmbH by Novartis AG, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Viatris Inc., and Zentiva Group, a.s..
Introducing 360iResearch AI: Revolutionizing Market Intelligence with AI-Powered Insights for the Branded Generics Market
We proudly unveil Research AI, a cutting-edge AI product designed to transform how businesses interact with the Branded Generics Market. Research AI stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, Research AI is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it's a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Branded Generics Market. Embrace the future of market analysis with Research AI, where informed decisions lead to remarkable growth.
Ask Question to Research AI @ https://www.360iresearch.com/library/intelligence/branded-generics?utm_source=openpr&utm_medium=referral&utm_campaign=research-ai
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Branded Generics Market, by Product
7. Branded Generics Market, by Drug Type
8. Branded Generics Market, by Route of Administration
9. Branded Generics Market, by Indication
10. Branded Generics Market, by Distribution Channel
11. Americas Branded Generics Market
12. Asia-Pacific Branded Generics Market
13. Europe, Middle East & Africa Branded Generics Market
14. Competitive Landscape
15. Competitive Portfolio
Read More @ https://www.360iresearch.com/library/intelligence/branded-generics?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Branded Generics Market worth $1,126.43 billion by 2030, growing at a CAGR of 14.66% - Exclusive Report by 360iResearch here
News-ID: 3587926 • Views: …
More Releases from 360iResearch
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Generics
Branded Generics Market: An In-depth Analysis
The pharmaceutical industry has long been a cornerstone of global healthcare, providing essential medications that save lives and improve quality of life. Within this vast sector, branded generics play a pivotal role, offering a unique blend of brand trust and cost-effectiveness. This article delves into the branded generics market, exploring its size, share, evolution, trends, and the factors driving its growth.
Introduction
Branded generics are off-patent drugs that are marketed under a…
A Complete Guide to Specialty Generics
The Specialty Generics Market is estimated to accelerate growth in the forecast period owing to driving factors such as the introduction of cost-effective drugs for the treatment of multiple sclerosis, cancer, and other infectious diseases, rise in the number of an off-patent specialty drug, early patent expirations are expected to boost the entry of new generics.
Grab PDF to Know More: - https://www.theinsightpartners.com/brochure/TIPRE00021203?utm_source=OpenPR&utm_medium=10209
Specialty generics are generic versions of specialty drugs…
Japan Generics Drug Market Japan Generics Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Japan Generic Drug Market
1.1 Reasons for Growth of Japan Generic Market
1.2 Some Misconceptions Related to Generic Drugs in Japan
2. Attractiveness of Japan Generic Market
2.1 Overview of Japan Pharmaceutical Market
2.2 Features of Japan Generic Drugs Market
2.3 Generic Drug Firms in Japan
2.4 Generic Drugs Import in Japan
…
Japan Generics Drug Market Outlook 2020
Japan is a small island nation located in East Asia and it is known for its economic prosperity. It sports one of the largest pharmaceutical markets like US and Europe due to which immense commercialization opportunities are present. Unique demographic structure and presence of advanced technology is the main reason for the growth of Japanese pharmaceutical industry. They have one of the most advanced research and development facilities across the…
US Cancer Generics Market Outlook 2022
“US Cancer Generics Market Outlook 2022” report gives comprehensive insight on the various indicators and trend analysis related to the emergence and integration of cancer generics drugs in mainstream pharmaceutical market in US. The report analyzes various clinical and non-clinical parameters responsible for the growth on cancer generics drugs in recent years. The introduction of generics has resulted in saving of billions of dollars for various stake holders involved US…
Global Cancer Generics Market Forecast to 2022
ReportsWorldwide has announced the addition of a new report title Global Cancer Generics Market Forecast to 2022 to its growing collection of premium market research reports.
Within the pharmaceutical industry, the oncology market is growing at a rapid pace owing to the rising incidences of cancer. In 2015, 15.2 Million new cancer cases were registered across the globe. This number is forecasted to increase to a value of 19.3 Million by…
